Retiring Arizona Prison Watch...

This site was originally started in July 2009 as an independent endeavor to monitor conditions in Arizona's criminal justice system, as well as offer some critical analysis of the prison industrial complex from a prison abolitionist/anarchist's perspective. It was begun in the aftermath of the death of Marcia Powell, a 48 year old AZ state prisoner who was left in an outdoor cage in the desert sun for over four hours while on a 10-minute suicide watch. That was at ASPC-Perryville, in Goodyear, AZ, in May 2009.

Marcia, a seriously mentally ill woman with a meth habit sentenced to the minimum mandatory 27 months in prison for prostitution was already deemed by society as disposable. She was therefore easily ignored by numerous prison officers as she pleaded for water and relief from the sun for four hours. She was ultimately found collapsed in her own feces, with second degree burns on her body, her organs failing, and her body exceeding the 108 degrees the thermometer would record. 16 officers and staff were disciplined for her death, but no one was ever prosecuted for her homicide. Her story is here.

Marcia's death and this blog compelled me to work for the next 5 1/2 years to document and challenge the prison industrial complex in AZ, most specifically as manifested in the Arizona Department of Corrections. I corresponded with over 1,000 prisoners in that time, as well as many of their loved ones, offering all what resources I could find for fighting the AZ DOC themselves - most regarding their health or matters of personal safety.

I also began to work with the survivors of prison violence, as I often heard from the loved ones of the dead, and learned their stories. During that time I memorialized the Ghosts of Jan Brewer - state prisoners under her regime who were lost to neglect, suicide or violence - across the city's sidewalks in large chalk murals. Some of that art is here.

In November 2014 I left Phoenix abruptly to care for my family. By early 2015 I was no longer keeping up this blog site, save occasional posts about a young prisoner in solitary confinement in Arpaio's jail, Jessie B.

I'm deeply grateful to the prisoners who educated, confided in, and encouraged me throughout the years I did this work. My life has been made all the more rich and meaningful by their engagement.

I've linked to some posts about advocating for state prisoner health and safety to the right, as well as other resources for families and friends. If you are in need of additional assistance fighting the prison industrial complex in Arizona - or if you care to offer some aid to the cause - please contact the Phoenix Anarchist Black Cross at PO Box 7241 / Tempe, AZ 85281.

until all are free -

MARGARET J PLEWS (June 1, 2015)


ANTICOLONIAL zines, stickers, actions, power

Taala Hooghan Infoshop

Kinlani/Flagstaff Mutual AID


The group for direct action against the prison state!

Black Lives Matter PHOENIX METRO

Black Lives Matter PHOENIX METRO
(accept no substitutions)



PHOENIX: Trans Queer Pueblo


AZ Prison Watch BLOG POSTS:

Sunday, August 21, 2011

FDA facilitating executions...

------------------------from the AZ Republic-------------------

E-mails detail FDA's efforts to avoid responsibility regarding execution drug

by Michael Kiefer
Aug. 20, 2011 12:00 AM
The Arizona Republic

In late September 2010, the Arizona Department of Corrections obtained the drug sodium thiopental from a small pharmaceutical supply house in London to carry out an execution by lethal injection in October.

The supply house was not registered with the U.S. Food and Drug Administration to export the drug, nor was the drug approved by FDA, but FDA officials in Phoenix nonetheless allowed the drug into the country.

Though the Corrections Department fought hard in court to keep the source of the drug secret, days before the October execution was carried out, The Arizona Republic learned that it had been imported from England.

From documents obtained this week from the FDA under the Freedom of Information Act, The Republic has learned that the revelation touched off inquiries into how the drug made it to Arizona and other states that had already been importing it from England and elsewhere.

Then, the FDA, the U.S. Drug Enforcement Administration and the U.S. Customs and Border Patrol all consulted with the White House to address questions about the legality of the imports and to justify bending the rules to get it to prisons for executions.

The documents released by the FDA offer an insider's view of an agency struggling to keep itself from being dragged into the national legal debate over drugs used in state executions. Some of the released documents were supposed to be redacted to conceal certain details, but encryption failed.

Those e-mails show, among other things, that the FDA, with the approval of unnamed persons at the White House, shifted responsibility for allowing the drug's import to Customs. That was done to avoid legal liability and to shield the FDA from any appearance of involvement with the death penalty.

One high-placed FDA official wrote on Nov. 2 that even if the agency issued a statement that it had not reviewed the drugs for "safety, efficacy or quality . . . it will insert FDA into the death-penalty cases because attorneys will try to use the statement as a means to open proceedings on the safety of the imported drugs."

By the end of 2010, the FDA officially stated it would "continue to defer to law enforcement on all matters involving lethal injection," and the e-mails show that it had deferred approval of the drug imports to Customs.

When asked for comment, Shelly Burgess, an FDA spokeswoman, said in an e-mail response, "This involves a matter in litigation and the agency does not comment on matters of litigation."

Dale Baich of the Federal Public Defender's Office in Phoenix, one of the plaintiffs in a lawsuit seeking to force the FDA to police the drug imports, also received the FDA documents whose redactions were visible. He said he declined to review them because of attorney ethical considerations.

"It is hard for me to say because I have not seen the documents," Baich said. "But it appears that the FDA was concerned, as were we, about how Arizona obtained the drugs. We have alleged the drugs were illegally imported and the FDA fell short in its duty under the law. This information seems to support our claims."

The American Civil Liberties Union of Northern California is also suing the FDA for information about thiopental imports, and this week's FOIA release was partly spurred by the ACLU's requests.

The FDA meanwhile, asked the federal public defender, the ACLU and The Republic to return the unredacted materials. The Republic declined.

By May 2010, sodium thiopental was scarce in the United States, and by late September of that year, as Arizona was preparing to execute its first prisoner in two years, the drug was virtually unavailable domestically because the only U.S. manufacturer had ceased production. Arizona, like other states, scrambled to find it overseas.

The first Arizona thiopental shipment cleared FDA approval on Sept. 28. In a timeline prepared months later, the FDA representative in Phoenix told his superiors that he "assumed entry would be legal."

But then the FDA representative found that Dream Pharma, the British supply house, was not authorized to export it to the U.S. Subsequent e-mails confirmed what Baich and others have said from the beginning: The drug was not approved for use in the United States.

The flurry of intra-agency e-mails of concern began Oct. 27, the day after Arizona executed death-row inmate Jeffrey Landrigan with British thiopental, and two days after The Republic revealed the drug's country of origin. FDA officials began tracking shipments to other states that had been allowed into the country.

By Nov. 5, e-mails were referring to FDA Commissioner Margaret Hamburg's request to investigate how to "extricate FDA from the process." On Nov. 9, the e-mails said the White House wanted the FDA to set up a conference to discuss the matter, even while FDA officials were still trying to figure out how to temporarily defuse the situation with Charles Flanagan, deputy director of the Arizona Department of Corrections. Flanagan was reportedly "very upset" and insisting that FDA personnel return his phone calls about further thiopental shipments that had been detained.

By Nov. 16, the e-mails asked whether the problem could be deferred to the DEA, and then by Nov. 22, the decision seemed made to "defer entirely to Customs." Into mid-December, the White House was asking for a detailed description of the FDA's plan to exercise enforcement discretion and not police thiopental shipments to prisons.

Then the federal government was forced to curtail the imports for another reason. According to one e-mail, the Georgia Department of Corrections asked the DEA to check if that agency had been authorized to import thiopental. It was not, and the DEA was forced to seize its supply of the drug in March. The e-mail goes on to say that the drug might not have been seized had Georgia not asked the question in the first place.

In late June, DEA officials told the Arizona Department of Corrections not to use thiopental in its execution of inmate Donald Beaty. A different drug was used instead and has been used since. It had almost been foretold in a March 16 memo from an FDA attorney.

"I am trying to test a hunch and that hunch is that between bad publicity, lawsuits, and product seizures, there will be less of a desire to bring this product in," he wrote.

Republic reporters JJ Hensley and Yvonne Wingett Sanchez contributed to this article.

No comments: